Download PDF
Horm Metab Res 2017; 49(02): 129-134
DOI: 10.1055/s-0042-121895
Endocrine Care
© Georg Thieme Verlag KG Stuttgart · New York

Basal Serum Calcitonin, After Calcium Stimulation, and in the Needle Washout of Patients with Thyroid Nodules and Mild or Moderate Basal Hypercalcitoninemia

P. W. Rosario
1   Santa Casa de Belo Horizonte, Minas Gerais, Brazil
,
M. R. Calsolari
1   Santa Casa de Belo Horizonte, Minas Gerais, Brazil
› Author Affiliations
Further Information

Publication History

received 19 September 2016

accepted 16 November 2016

Publication Date:
06 February 2017 (online)

Also available at
    Permissions and Reprints

Abstract

This prospective study evaluated the concentrations of basal serum calcitonin (Ctn), Ctn after stimulation with calcium, and Ctn in the needle washout (FNA-Ctn) as predictors of sporadic medullary thyroid carcinoma (MTC) in patients with thyroid nodules and basal Ctn between 10 and 100 pg/ml. Forty-one patients were included in the study. MTC was diagnosed in only 6 patients (14.6%). None of the patients with basal Ctn≤24.6 pg/ml (n=26) or stimulated Ctn≤186.5 pg/ml (n=21) had MTC. All patients without MTC had basal Ctn<47 pg/ml and stimulated Ctn<655.2 pg/ml. Among patients with basal Ctn between 24.6 and 47 pg/ml (n=12), 3 (25%) had MTC. Among patients with stimulated Ctn between 186.5 and 655.2 pg/ml (n=18), 4 (22.2%) had MTC. FNA-Ctn distinguished nodules that were MTC (n=6) from those that were not (n=60), without overlapping results. In the calcium stimulation test, 19 patients (46.3%) reported some adverse effect, but none of them was severe or required specific treatment. Our results highlight that in patients without a history suspicious for MTC, mild or moderate basal hypercalcitoninemia should not establish the diagnosis of this tumor. Depending on the concentration found, basal Ctn should be sufficient to define patient management. In doubtful cases, FNA-Ctn seems to be the best diagnostic test. Calcium stimulation testing was safe, but more studies are needed to determine the Ctn cutoff after stimulation with calcium.

Key words

thyroid nodule - hypercalcitoninemia - calcium stimulation test - medullary thyroid carcinoma
 

  • References

  • 1 Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Endocr Pract 2010; 16: 1-43
    CrossrefPubMedGoogle Scholar
  • 2 Pacini F, Castagna MG, Brilli L, Pentheroudakis G. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23 (Suppl. 07) 110-119
    PubMedGoogle Scholar
  • 3 Niccoli P, Wion-Barbot N, Caron P, Henry JF, De Micco E, Saint Andre JP, Bigorgne JC, Modigliani E, Conte-Devolx B. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. J Clin Endocrinol Metab 1997; 82: 338-341
    CrossrefPubMedGoogle Scholar
  • 4 Papi G, Corsello SM, Cioni K, Pizzini AM, Corrado S, Carapezzi C, Fadda G, Baldini A, Carani C, Pontecorvi A, Roti E. Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study. J Endocrinol Invest 2006; 29: 427-437
    CrossrefPubMedGoogle Scholar
  • 5 Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 2007; 92: 450-455
    CrossrefPubMedGoogle Scholar
  • 6 Chambon G, Alovisetti C, Idoux-Louche C, Reynaud C, Rodier M, Guedj AM, Chapuis H, Lallemant JG, Lallemant B. The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disordes: results from 2733 consecutive patients. J Clin Endocrinol Metab 2011; 96: 75-81
    CrossrefPubMedGoogle Scholar
  • 7 Rosario PW, Penna GC, Brandão K, Souza BE. Usefulness of preoperative serum calcitonin in patients with nodular thyroid disease without suspicious history or cytology for medullary thyroid carcinoma. Arq Bras Endocrinol Metabol 2013; 57: 312-316
    CrossrefPubMedGoogle Scholar
  • 8 Iacobone M, Niccoli-Sire P, Sebag F, DeMicco C, Henry JF. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels. World J Surg 2002; 26: 886-890
    CrossrefPubMedGoogle Scholar
  • 9 Scheuba C, Kaserer K, Moritz A, Drosten R, Vierhapper H, Bieglmayer C, Haas OA, Niederle B. Sporadic hypercalcitoninemia: clinical and therapeutic consequences. Endocr Relat Cancer 2009; 16: 243-253
    PubMedGoogle Scholar
  • 10 Schneider C, Kobe C, Schmidt M, Kahraman D, Malchau G, Faust M, Schicha H, Dietlein M. Calcitonin screening in patients with thyroid nodules. Diagnostic value. Nuklearmedizin 2012; 51: 228-233
    PubMedGoogle Scholar
  • 11 Kwon H, Kim WG, Choi YM, Jang EK, Jeon MJ, Song DE, Baek JH, Ryu JS, Hong SJ, Kim TY, Kim WB, Shong YK. A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma. Clin Endocrinol 2015; 82: 598-603
    CrossrefPubMedGoogle Scholar
  • 12 Mian C, Perrino M, Colombo C, Cavedon E, Pennelli G, Ferrero S, De Leo S, Sarais C, Cacciatore C, Irene Manfredi G, Verga U, Iacobone M, De Pasquale L, Pelizzo MR, Vicentini L, Persani L, Fugazzola L. Refining calcium test for the diagnosis of medullary thyroid cancer: cut-offs, procedures and safety. J Clin Endocrinol Metabol 2014; 99: 1656-1664
    CrossrefPubMedGoogle Scholar
  • 13 Trimboli P, Guidobaldi L, Crescenzi A, Bongiovanni M, Giovanella L. The essential use of FNA-calcitonin for detecting medullary thyroid cancer. Endocrine 2014; 47: 342-344
    CrossrefPubMedGoogle Scholar
  • 14 Doyle P, Duren C, Nerlich K, Verburg FA, Grelle I, Jahn H, Fassnacht M, Mäder U, Reiners C. Luster M. Potency and tolerance of calcitonin stimulation with high-dose calcium vs. pentagastrin in normal adults. J Clin Endocrinol Metab 2009; 94: 2970-2974
    CrossrefPubMedGoogle Scholar
  • 15 Colombo C, Verga U, Mian C, Ferrero S, Perrino M, Vicentini L, Dazzi D, Opocher G, Pelizzo MR, Beck-Peccoz P, Fugazzola L. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J Clin Endocrinol Metab 2012; 97: 905-913
    CrossrefPubMedGoogle Scholar
  • 16 Giovanella L. Serum procalcitonin and calcitonin normal values before and after calcium gluconate infusion. Exp Clin Endocrinol Diabetes 2012; 120: 169-170
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Lorenz K, Elwerr M, Machens A, Abuazab M, Holzhausen HJ, Dralle H. Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin. Langenbeck Arch Surg 2013; 398: 403-409
    CrossrefPubMedGoogle Scholar
  • 18 Papadakis G, Keramidas I, Triantafillou E, Kanouta F, Pappa T, Kaltzidou V, Tertipi A, Iordanidou L, Trivizaki E, Vecchini G, Villiotou V, Pappas A. Association of basal and calcium-stimulated calcitonin levels with pathological findings after total thyroidectomy. Anticancer Res 2015; 35: 4251-4258
    PubMedGoogle Scholar
  • 19 Kihara M, Miyauchi A, Kudo T, Hirokawa M, Miya A. Reference values of serum calcitonin with calcium stimulation tests by electrochemiluminescence immunoassay before/after total thyroidectomy in Japanese patients with thyroid diseases other than medullary thyroid carcinoma. Endocr J 2016; 63: 627-632
    CrossrefPubMedGoogle Scholar
  • 20 Wells Jr AS, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee NY, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal S, Santoro M, Schlumberger M, Shah MH, Waguespack SG. Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma The American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Thyroid 2015; 25: 567-610
    CrossrefPubMedGoogle Scholar
  • 21 Trimboli P, Cremonini N, Ceriani L, Saggiorato E, Guidobaldi L, Romanelli F, Ventura C, Laurenti O, Messuti I, Solaroli E, Madaio R, Bongiovanni M, Orlandi F, Crescenzi A, Valabrega S, Giovanella L. Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study. Clin Endocrinol 2014; 80: 135-140
    CrossrefPubMedGoogle Scholar
  • 22 Essig GF, Porter K, Schneider D, Debora A, Lindsey SC, Busonero G, Fineberg D, Fruci B, Boelaert K, Smit JW, Meijer JA, Duntas L, Sharma N, Costante G, Filetti S, Sippel RS, Biondi B, Topliss DJ, Pacini F, Maciel RM, Walz PC, Kloos RT. Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone. Endocr Pract 2013; 19: 920-927
    CrossrefPubMedGoogle Scholar
  • 23 Trimboli P, Treglia G, Guidobaldi L, Romanelli F, Nigri G, Valabrega S, Sadeghi R, Crescenzi A, Faquin WC, Bongiovanni M, Giovanella L. Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis. Clin Endocrinol 2015; 82: 280-285
    CrossrefPubMedGoogle Scholar
  • 24 Ahmed SR, Ball DW. Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment. J Clin Endocrinol Metab 2011; 96: 1237-1245
    CrossrefPubMedGoogle Scholar
  • 25 Wirth LJ, Ross DS, Randolph GW, Cunnane ME, Sadow PM. Case records of the Massachusetts General Hospital. Case 5-2013. A 52-year-old woman with a mass in the thyroid. N Engl J Med 2013; 368: 664-673
    CrossrefPubMedGoogle Scholar
  • 26 Trimboli P, Nigri G, Romanelli F, Cicciarella Modica DD, Crescenzi A, Valabrega S, Giovanella L. Medullary thyroid nodules by measurement of calcitonin (Ct) in aspiration needle washout in patients with multinodular goiter and moderately elevated serum Ct. Exp Clin Endocrinol Diabetes. 2012; 120: 234-237
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Boi F, Maurelli I, Pinna G, Atzeni F, Piga M, Lai ML, Mariotti S. Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma. J Clin Endocrinol Metab 2007; 92: 2115-2118
    CrossrefPubMedGoogle Scholar
  • 28 Kudo T, Miyauchi A, Ito Y, Takamura Y, Amino N, Hirokawa M. Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid 2007; 17: 635-638
    CrossrefPubMedGoogle Scholar
  • 29 Diazzi C, Madeo B, Taliani E, Zirilli L, Romano S, Granata AR, De Santis MC, Simoni M, Cioni K, Carani C, Rochira V. The diagnostic value of calcitonin measurement in wash-out fluid from fine-needle aspiration of thyroid nodules in the diagnosis of medullary thyroid cancer. Endocr Pract 2013; 19: 769-779
    CrossrefPubMedGoogle Scholar
  • 30 Trimboli P, Guidobaldi L, Bongiovanni M, Crescenzi A, Alevizaki M, Giovanella L. Use of fine-needle aspirate calcitonin to detect medullary thyroid carcinoma: A systematic review. Diagn Cytopathol 2016; 44: 45-51
    CrossrefPubMedGoogle Scholar